Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/07/2002 | WO2002087623A1 Microparticle protection of therapeutic agents |
11/07/2002 | WO2002087621A1 Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
11/07/2002 | WO2002087614A2 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
11/07/2002 | WO2002087603A1 Immunopotentiators |
11/07/2002 | WO2002087602A1 Granulated product and process for producing tablets |
11/07/2002 | WO2002087597A1 Oral delivery of macromolecules |
11/07/2002 | WO2002087596A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases |
11/07/2002 | WO2002087592A1 Injectable pamidronate disodium |
11/07/2002 | WO2002087586A1 Sustained release drug delivery system containing codrugs |
11/07/2002 | WO2002087572A1 Triazole derivative solution preparations |
11/07/2002 | WO2002087570A1 Composition comprising antifungal agents for treating vulvovaginitis and vaginosis |
11/07/2002 | WO2002087563A2 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
11/07/2002 | WO2002087548A1 A pharmaceutical tablet having a high api content |
11/07/2002 | WO2002087546A2 Method for manufacturing a low dose pharmaceutical composition |
11/07/2002 | WO2002087545A1 Composition and methods for treatment of hyperplasia |
11/07/2002 | WO2002087542A1 Novel methods and compositions for delivering macromolecules to or via the respiratory tract |
11/07/2002 | WO2002087541A1 Lipid-based formulations for gene transfer |
11/07/2002 | WO2002087510A2 Subcellular targeting of therapeutic proteins |
11/07/2002 | WO2002087509A2 Colloidal metal compositions and methods |
11/07/2002 | WO2002087508A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
11/07/2002 | WO2002087500A2 Viral enzyme activated prototoxophores and use of same to treat viral infections |
11/07/2002 | WO2002087498A2 Diagnostic imaging compositions, their methods of synthesis and use |
11/07/2002 | WO2002087497A2 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
11/07/2002 | WO2002087494A2 Novel vaccine |
11/07/2002 | WO2002087482A1 Abuse resistant opioid containing transdermal systems |
11/07/2002 | WO2002087424A2 Treatment and diagnosis of macrophage mediated disease |
11/07/2002 | WO2002087338A1 Liquid formulations for dermal application in treatment of parasitic insects in animals |
11/07/2002 | WO2002087326A1 Compositions including vitamin-based surfactants ad methods for using same |
11/07/2002 | WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis |
11/07/2002 | WO2002056913A3 Stabilized brivudine topical formulations containing metal oxide pigments |
11/07/2002 | WO2002055023A3 Therapeutic film forming composition and treatment system |
11/07/2002 | WO2002055021A3 Glycopolymers and free radical polymerization methods |
11/07/2002 | WO2002051421A3 Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
11/07/2002 | WO2002047693A3 Steroid hormone products comprising a stabilizing agent in non-crystalline form |
11/07/2002 | WO2002045681A3 Solid polyunsaturated fatty acid compositions |
11/07/2002 | WO2002038132A3 Soft capsules comprising a starch mixture having a reduced branching degree |
11/07/2002 | WO2002026867A3 Dendrimeric support or carrier macromolecule |
11/07/2002 | WO2002009769A3 Therapeutic azo-compounds for drug delivery |
11/07/2002 | WO2002009768A3 Therapeutic polyesters and polyamides |
11/07/2002 | WO2002009767A3 Therapeutic polyanhydride compounds for drug delivery |
11/07/2002 | WO2002009667A3 Dispersions for formulating slightly or poorly soluble active ingredients |
11/07/2002 | WO2001015745A9 Method and formula for tumor remission and suppression of cancer |
11/07/2002 | WO2001010454A9 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection |
11/07/2002 | WO2001001929A3 Microcapsules iv |
11/07/2002 | US20020165359 Gelatin for use in the generation of films on capsules |
11/07/2002 | US20020165342 Glucagon-like insulinotropic peptides, compositions and methods |
11/07/2002 | US20020165287 Composition based on alkyl polyglycosides and fatty alcohols, and its uses |
11/07/2002 | US20020165286 Lipophilic excipient capable of dissolving the drug, targeting to the pilosebaceous ducts on the skin; antiacne |
11/07/2002 | US20020165265 Microtubule disrupter such as paclitaxel, and a polymeric carrier that is NOT a capsule; embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions |
11/07/2002 | US20020165254 Autoclavable pharmaceutical compositions containing a chelating agent |
11/07/2002 | US20020165249 Nasal delivery of apomorphine |
11/07/2002 | US20020165220 Topical dispersion; water solutions; evaporation |
11/07/2002 | US20020165211 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
11/07/2002 | US20020165184 Forming a polymer in the presence of a biologically active drug for delivery to a cell; cationic polyamine compounds for conjugation with polyethylene glycol and complexing with nucleic acids |
11/07/2002 | US20020165179 Multifunctional nanodevice platform |
11/07/2002 | US20020165164 New effectors of dipeptidyl peptidase IV for topical use |
11/07/2002 | US20020165146 Follicle stimulating hormone (FSH) products used in the treatment of infertility |
11/07/2002 | US20020165134 Emulsion preconcentrates; triglyceride mixture |
11/07/2002 | US20020165131 Histidine-rich glycoprotein |
11/07/2002 | US20020165126 Method for inactivating gonadotrophs |
11/07/2002 | US20020164799 Expression vector coding proteins for use in the treatment of cancer |
11/07/2002 | US20020164758 Enzymatic polypeptide for use in the diagnosis and treatment of allergies, heart and respiratory disorders |
11/07/2002 | US20020164719 Targeting pharmaceutical agents to injured tissues |
11/07/2002 | US20020164648 Injection of chemical intermediates into mammalian cells; obtain cells, inject with ligand joined colloid, detect signal from ligand |
11/07/2002 | US20020164389 Method for topical treatment of carpal tunnel syndrome |
11/07/2002 | US20020164381 Mixture containing sulfur and sulfur compound |
11/07/2002 | US20020164377 Mixture of retinoic acid and paclitaxel; polymeric carrier |
11/07/2002 | US20020164376 Microparticles and their use in cancer treatment |
11/07/2002 | US20020164374 Biodegradation insert; mixture of drug and polymer |
11/07/2002 | US20020164373 Opioid sustained-released formulation |
11/07/2002 | US20020164372 Controlled release systems for polymers |
11/07/2002 | US20020164366 Transdermal delivery system |
11/07/2002 | US20020164365 Multifaceted compositions for post-surgical adhesion prevention |
11/07/2002 | US20020164362 Cosmetic product containing shellac |
11/07/2002 | US20020164359 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
11/07/2002 | US20020164352 Dietetics; anticholesterol agents; antidiabetic agents |
11/07/2002 | US20020164347 Neoglycoproteins |
11/07/2002 | US20020164338 Combined approach to treatment of cancer with hCG vaccines |
11/07/2002 | US20020164331 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
11/07/2002 | US20020164315 Polyampholytes for delivering polyions to a cell |
11/07/2002 | US20020164305 Integrin fusion protein; binding to antibodies |
11/07/2002 | US20020164302 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
11/07/2002 | US20020164301 Methods for inhibiting atherosclerotic plaque formation |
11/07/2002 | US20020164290 Biocompatible compounds for sustained release pharmaceutical drug delivery systems |
11/07/2002 | US20020164288 Fullerene (C60) -based X-ray contrast agent for diagnostic imaging |
11/07/2002 | US20020164287 Azo compounds for type i phototherapy |
11/07/2002 | DE10120092A1 Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung Gastro-resistant device for releasing of mucoadhesive drug carriers and procedures for preparing the enteric device |
11/07/2002 | DE10109897A1 Fakultativ kationische Liposomen und Verwendung dieser Optional cationic liposomes and use of these |
11/07/2002 | CA2747159A1 Biodegradable elastomer and method of preparing same |
11/07/2002 | CA2715570A1 Cripto blocking antibodies and uses thereof |
11/07/2002 | CA2454601A1 Microparticle protection of therapeutic agents |
11/07/2002 | CA2448607A1 Colloidal metal compositions and methods |
11/07/2002 | CA2446491A1 Compositions including vitamin-based surfactants ad methods for using same |
11/07/2002 | CA2446083A1 Composition and methods for treatment of hyperplasia |
11/07/2002 | CA2446064A1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
11/07/2002 | CA2446052A1 Compositions and methods for treating vulvovaginitis and vaginosis |
11/07/2002 | CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production |
11/07/2002 | CA2445860A1 Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
11/07/2002 | CA2445826A1 Treatment and diagnosis of macrophage mediated disease |
11/07/2002 | CA2445763A1 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |